In this article, we are going to take a look at where Teva Pharmaceuticals Industries Limited (NYSE:TEVA) stands against other best weight loss drug stocks to buy according to analysts.

Axsome Therapeutics shares were up 14% in premarket trading after reaching a settlement with Teva Pharmaceuticals. Shares were trading around $120.01. The stock is up 8.3% over the last year.

Corebridge Financial Inc. lessened its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 2.3% during the fourth quarter, Holdings Channel.com reports.

This marks the second biosimilar released in the U.S. by the strategic partnership between Teva Pharmaceuticals and Alvotech, which is committed to providing more affordable treatment options.

Regeneron and Teva have announced positive top-line phase ... with placebo at eight to 12-week time points. At Reuters Pharma USA, editor-in-chief Jonah Comstock caught up with Brian Hilberdink ...

Financial giants have made a conspicuous bearish move on Teva Pharmaceutical Indus. Our analysis of options history for Teva Pharmaceutical Indus TEVA revealed 8 unusual trades. Delving into the ...

A leader in CNS specialty medicine sales in the United States and in the top five globally, Teva Pharmaceuticals is actively looking to expand its CNS portfolio further.